Despite excluding pregnant women with diagnosed gestational diabetes mellitus (GDM), many of the metabolic pathways we found to be upregulated in ICP were related to type II diabetes mellitus, insulin resistance, and insulin secretion. This evidence concerns the gene INS and Insulin resistance.